Evoke Pharma Inc (EVOK)
4.366
+0.11
(+2.48%)
USD |
NASDAQ |
Nov 14, 16:00
4.56
+0.19
(+4.45%)
After-Hours: 20:00
Evoke Pharma Total Return Level: 4.366 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 4.366 |
November 13, 2024 | 4.26 |
November 12, 2024 | 5.00 |
November 11, 2024 | 5.38 |
November 08, 2024 | 5.65 |
November 07, 2024 | 5.653 |
November 06, 2024 | 5.84 |
November 05, 2024 | 5.79 |
November 04, 2024 | 5.72 |
November 01, 2024 | 5.80 |
October 31, 2024 | 5.85 |
October 30, 2024 | 6.45 |
October 29, 2024 | 6.30 |
October 28, 2024 | 7.08 |
October 25, 2024 | 5.30 |
October 24, 2024 | 5.13 |
October 23, 2024 | 5.13 |
October 22, 2024 | 5.40 |
October 21, 2024 | 5.48 |
October 18, 2024 | 5.51 |
October 17, 2024 | 5.336 |
October 16, 2024 | 5.14 |
October 15, 2024 | 5.11 |
October 14, 2024 | 5.090 |
October 11, 2024 | 5.19 |
Date | Value |
---|---|
October 10, 2024 | 5.32 |
October 09, 2024 | 5.17 |
October 08, 2024 | 5.57 |
October 07, 2024 | 5.38 |
October 04, 2024 | 5.25 |
October 03, 2024 | 5.20 |
October 02, 2024 | 4.95 |
October 01, 2024 | 4.870 |
September 30, 2024 | 4.76 |
September 27, 2024 | 4.81 |
September 26, 2024 | 5.08 |
September 25, 2024 | 4.80 |
September 24, 2024 | 5.00 |
September 23, 2024 | 5.26 |
September 20, 2024 | 4.51 |
September 19, 2024 | 4.44 |
September 18, 2024 | 4.24 |
September 17, 2024 | 4.36 |
September 16, 2024 | 4.221 |
September 13, 2024 | 4.31 |
September 12, 2024 | 4.19 |
September 11, 2024 | 4.020 |
September 10, 2024 | 4.10 |
September 09, 2024 | 4.110 |
September 06, 2024 | 3.87 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.87
Minimum
Sep 06 2024
820.80
Maximum
Aug 14 2020
148.12
Average
53.28
Median
Apr 06 2022
Total Return Level Benchmarks
Repligen Corp | 142.43 |
Eli Lilly and Co | 2270.02 |
MEI Pharma Inc | 3.868 |
Revance Therapeutics Inc | 4.31 |
NovaBay Pharmaceuticals Inc | 0.727 |